NCPDP Foundation - Home

About the Foundation
The NCPDP Foundation funds research that can transform the way your healthcare providers communicate with one another and with you, leading to better and safer healthcare. Our focus is on increasing the use of standards to make the electronic exchange of healthcare information more accurate, complete and timely.
Learn More >
Research Priorities
Industry standards provide the framework for an interoperable healthcare ecosystem with better communication and coordination among everyone involved in a patient’s care. Donations to the NCPDP Foundation fund research and pilots to accelerate adoption of those standards. The priority is on projects that validate the benefits of implementing NCPDP standards that improve medication safety, timely access to needed medications, and adherence to medication therapies.
Learn More >
Recent Grants
Most recently, the Foundation awarded grants for projects that will help: prevent unnecessary dispensing of controlled substances, thereby helping to abate the opioid crisis; provide prescription benefit and patient out-of-pocket cost information at the point of care to increase speed to therapy and adherence to medications; decrease adverse events that harm patients when a prescription is discontinued, but not cancelled.
Learn More >

NCPDP Foundation Awards $100,000 to Support Real-Time Prescription Benefit (RTPB) Standard Projects at DrFirst and Johns Hopkins Medicine

The NCPDP Foundation Board of Trustees, who govern the 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, has approved $100,000 in funding to support two research projects piloting the Beta version of NCPDP’s Real-Time Prescription Benefit (RTPB) Standard.
Read More

Call for Grant Proposals for Real-time Prescription Benefit Research Project

The NCPDP Foundation is interested in awarding a grant of up to $50,000 to fund a proof of concept pilot research project on the BETA version NCPDP Real-Time Prescription Benefit (RTPB) Standard. The BETA Standard was approved by NCPDP members during the recent NCPDP Joint Technical Work Group Meetings. Grant proposals are due to the Foundation by September 30, 2019, with an announcement of the grant award to be made by November 30, 2019. Read More

NCPDP Foundation Names Former U.S. Rear Admiral Pam Schweitzer to its Board of Trustees

The NCPDP Foundation, a 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, announced today that former Assistant Surgeon General and Chief Pharmacist of the U.S. Public Health Service (PHS), Rear Admiral (RADM) Pam Schweitzer, Pharm.D., will join its NCPDP Foundation Board effectively immediately. Read More

Johns Hopkins Study Affirms Benefit of CancelRx and Leads to Enhancements

A Johns Hopkins Medicine study, funded by a $42,000 NCPDP Foundation grant, affirms the important function of the CancelRx ePrescribing transaction in decreasing adverse patient events due to medication errors, and will lead to the transaction becoming even more valuable in improving patient safety. CancelRx is an underused transaction in the NCPDP SCRIPT Standard for ePrescribing that enables prescribers to electronically cancel a prescription already submitted to a pharmacy. Read More

New Grant Helps Advance Pharmacist eCare Plan

The Foundation recently approved a $25,000 grant to the NCPA Innovation Center to help support further development of the Pharmacist eCare Plan and its adoption as a national standard. WG10 Professional Pharmacy Services initially developed the Pharmacist eCare Plan to enable pharmacists to capture their assessments of patient health status and health concerns, mutually defined patient care goals, recommendations, interventions and outcomes and to share them with other care providers, payers and the patient.

NCPDP Grant Will Demonstrate Impact of CancelRx with Controlled Substance Prescriptions

Another NCPDP Foundation grant of $36,000 to the University of Wisconsin-Madison, School of Pharmacy will demonstrate how the use of CancelRx impacts the cancellation and dispensing of controlled substance prescriptions. Use of the Cancel Rx electronic transaction can potentially minimize the number of extraneous or unnecessary controlled substance medications that are dispensed and available to patients, thereby helping to abate the opioid crisis.

Foundation Receives $1 Million Mary and Charles D. Pulido Endowment

The Foundation recently received a $1,000,000 endowment from NCPDP in honor of Mary and Charles D. Pulido. Charlie is the sole surviving co-founder of NCPDP and a founding Board member of the NCPDP Foundation. For more than 40 years, Charlie has been a passionate supporter and valued ambassador for NCPDP and now the NCPDP Foundation. Charlie and his wife, Mary, have personally donated generously to the Foundation. The endowment is a restricted fund intended to help sustain the Foundation in the long run. The principal cannot be touched -- however a percent of the interest can be used to support the Foundation’s work. The intention is for the principal to continue to grow and help ensure that the Foundation endures so its work will continue in perpetuity.

1977 Society Launches with 31 Inaugural Donors and $61,287

The Foundation announced its new 1977 Society annual giving donor program on May 7 during the NCPDP Annual Conference in Scottsdale, Arizona. The Society recognizes donors who support the Vision and Purpose of the NCPDP Foundation by providing monetary donations totaling $1,977 or more within a calendar year. Read More

2019 Annual Fund Campaign Exceeds Expectations

Our first Annual Fund Giving Campaign has exceeded expectations – a sign that prospective donors are learning more about the NCPDP Foundation and potential value of projects funded through donations to the Foundation. We had hoped to reach 50% of the $100,000 goal for the 2019 Annual Fund Campaign by the end of NCPDP’s Annual Conference. We did better! As a result of proceeds from the Foundation’s fundraising events held in conjunction with the NCPDP conference, and the heartening response to the 1977 Society, we have reached 110% of our goal.
Read More